<DOC>
	<DOCNO>NCT01513369</DOCNO>
	<brief_summary>The purpose study investigate correlation HbA1c iron status Type 2 Diabetes mellitus patient iron deficiency intravenous substitution iron .</brief_summary>
	<brief_title>Ferric Carboxymaltose Type 2 Diabetes Mellitus ( T2DM ) Patients With Iron Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>T2DM patient diagnosis ID define follow : serum ferritin &lt; 150 ng/mL TSAT &lt; 25 % Hb &lt; 14 g/dL serum ferritin &lt; 100 ng/mL TSAT &lt; 20 % Hb ≥ 14 g/dL ≤ 15g/dL ] HbA1c : ≥ 6.5 &lt; 8.5 % Age &gt; 18 year Written inform consent obtain . Continuous subcutaneous insulin infusion ( CSII ) thalassaemia Hb &gt; 15 g/dL ( &gt; 9,31 mmol/L ) Change HbA1c ±0,3 % within last 3 month . know sensitivity ferric carboxymaltose history acquire iron overload History erythropoietin stimulating agent , i.v . iron therapy , and/or blood transfusion previous 12 week prior randomisation History oral iron therapy dose ≥ 100 mg/day 1 week prior randomisation . Note : Ongoing oral use multivitamin contain iron &lt; 75 mg/day permit . Body weight ≤ 40 kg CRP &gt; 15 mg/L Chronic liver disease ( include know active hepatitis ) and/or screen alanine transaminase ( ALAT ) aspartate transaminase ( ASAT ) &gt; 3 x ULN ( upper limit normal range ) . Subjects know hepatitis B surface antigen positivity and/or Hepatitis C virus ribonucleic acid positivity . Vitamin B12 and/or serum folate deficiency . If deficiency correct subject may rescreened inclusion . Subjects know seropositivity human immunodeficiency virus . Clinical evidence current malignancy exception basal cell squamous cell carcinoma skin , cervical intraepithelial neoplasia . Currently receive systemic chemotherapy and/or radiotherapy . Renal dialysis ( previous , current plan within next 6 month ) . Renal function GFR &lt; 30 mL/min/ 1.73m2 ( severe ) Unstable angina pectoris judge Investigator ; severe valvular leave ventricular outflow obstruction disease need intervention ; atrial fibrillation/flutter mean ventricular response rate rest &gt; 100 beat per minute . Acute myocardial infarction acute coronary syndrome , transient ischaemic attack stroke within last 3 month prior randomisation . Coronaryartery bypass graft , percutaneous intervention ( e.g. , cardiac , cerebrovascular , aortic ; diagnostic catheter allow ) major surgery , include thoracic cardiac surgery , within last 3 month prior randomisation . Patients polyneuropathy without ischemia . Subject childbearing potential pregnant ( e.g. , positive human chorionic gonadotropin test ) breast feeding . Any subject willing use adequate contraceptive precaution study 5 day last scheduled dose study medication . Participation interventional trial Female subject childbearing potential pregnant ( e.g. , positive human chorionic gonadotropin test ) breast feeding . Failure use highlyeffective contraceptive method Persons kind dependency investigator employ sponsor investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>iron deficiency</keyword>
</DOC>